[Hot Topics] All About New Data of Antithrombotics

April 26, 2024 / 4:40 PM ~ 6:06 PM 📌 Presentation Room 1, Level 1

Moderator(s): Dominick J. Angiolillo, Duk-Woo Park
Panelist(s): Sripal Bangalore, David Joel Cohen, Byeong-Keuk Kim, Tullio Palmerini, Kyung Woo Park, Pieter Smits, Hiroyoshi Yokoi


Antiplatelet Issues

  • Standardizing the Language on Bleeding and Ischemic Risks: Insights on ARC, BARC, VARC, and Others
    Pieter Smits
  • Escalation Strategy of Antithrombotic Therapy: Why, in Whom, and How?
    Tullio Palmerini
  • De-Escalation Strategy of Antithrombotic Therapy: Why, in Whom, and How?
    Sripal Bangalore
  • Escalation and De-Escalation Strategy for CHIP-PCI Patients: The TAILORED-CHIP Trial
    Duk-Woo Park
  • Panel Discussion l

Anticoagulation Issues

  • Don't Forget About Dual Pathway Inhibition: When DOAC Should Not Be Standard Treatment
    Dominick J. Angiolillo
  • Factor XI Inhibitors in Availalbe RCTs: A Meta-analysis and Future Perspectives
    Roxana Mehran
  • Long-term DOAC Management of AF and Stable CAD: Expectation on the EPIC-CAD Trial After the AFIRE Trial
    Gi-Byoung Nam
  • Panel Discussion ll
Share this Post: